Some Biologic Treatments for Psoriasis May Be Safer for Patients
An observational cohort study suggests there is less risk of serious infection in patients taking newer, targeted systemic medications for psoriasis.
An observational cohort study suggests there is less risk of serious infection in patients taking newer, targeted systemic medications for psoriasis.
Allergan Aesthetics’ Heidi Shurtz discusses updates to the APP loyalty program, including simplified savings, greater pricing transparency, and new benefits for growing aesthetics practices.